Altimmune sets 2026 annual meeting for April 16; proposal deadline Feb 13

Altimmune, Inc.

Annual meeting scheduled for April 16, 2026; record date is March 13, 2026.
Stockholder proposals for inclusion in proxy must be received by February 13, 2026.
Director nominations under bylaws and universal proxy rule due by February 13 and February 15, 2026, respectively.

item 8.01

Altimmune, Inc. filing history →

Source: SEC EDGAR

accession 0001326190-26-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.